Table 2.
Conditions for discontinuation of itraconazole therapy in AIDS patients with disseminated histoplasmosis on highly active antiretroviral therapy

Conditions for discontinuation of itraconazole therapy in AIDS patients with disseminated histoplasmosis on highly active antiretroviral therapy
